Curia (RNA/Advanced) vs ST Pharm: CDMO Comparison
How does Curia (RNA/Advanced) compare to ST Pharm for mRNA/LNP manufacturing?
Side-by-side comparison of Curia (RNA/Advanced) and ST Pharm on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Curia (RNA/Advanced) has FDA inspections on record (2); ST Pharm does not yet appear in the FDA inspection database.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Curia (RNA/Advanced) holds 18 active EMA GMP certificates; ST Pharm does not appear in EudraGMDP.
On a 13-modality CDMO landscape, both Curia (RNA/Advanced) and ST Pharm qualify as mRNA/LNP manufacturers; Curia (RNA/Advanced) carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both Curia (RNA/Advanced) and ST Pharm qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: Curia (RNA/Advanced) vs ST Pharm
How does Curia (RNA/Advanced) compare to ST Pharm for mRNA/LNP manufacturing?
On CDMO Signal's composite Signal Score, Curia (RNA/Advanced) is 79/100 and ST Pharm is 73/100; Curia (RNA/Advanced) has 2 FDA inspections on record vs 0 for ST Pharm; European coverage is 18 active EMA+MHRA certificates for Curia (RNA/Advanced) vs 0 for ST Pharm. Both are tracked in the CDMO Signal directory as mRNA/LNP CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Curia (RNA/Advanced) or ST Pharm?
Both Curia (RNA/Advanced) and ST Pharm maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Curia (RNA/Advanced) has 2 FDA inspections on record; ST Pharm has 0.
How do Curia (RNA/Advanced) and ST Pharm compare on European GMP coverage?
Curia (RNA/Advanced) holds 18 active EMA GMP certificates and 0 MHRA / UK certificates. ST Pharm holds 0 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is better for mRNA/LNP manufacturing — Curia (RNA/Advanced) or ST Pharm?
Both Curia (RNA/Advanced) and ST Pharm are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Curia (RNA/Advanced) carries a Signal Score of 79/100 and ST Pharm carries 73/100 — a small lead for Curia (RNA/Advanced). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →